Liver pathology in COVID-19 related death and leading role of autopsy in the pandemic
- PMID: 36683722
- PMCID: PMC9850946
- DOI: 10.3748/wjg.v29.i1.200
Liver pathology in COVID-19 related death and leading role of autopsy in the pandemic
Abstract
Background: Information on liver involvement in patients with coronavirus disease 2019 is currently fragmented.
Aim: To highlight the pathological changes found during the autopsy of severe acute respiratory syndrome coronavirus 2 positive patients.
Methods: A systematic literature search on PubMed was carried out until June 21, 2022.
Results: A literature review reveals that pre-existing liver disease and elevation of liver enzyme in these patients are not common; liver enzyme elevations tend to be seen in those in critical conditions. Despite the poor expression of viral receptors in the liver, it seems that the virus is able to infect this organ and therefore cause liver damage. Unfortunately, to date, the search for the virus inside the liver is not frequent (16% of the cases) and only a small number show the presence of the virus. In most of the autopsy cases, macroscopic assessment is lacking, while microscopic evaluation of livers has revealed the frequent presence of congestion (42.7%) and steatosis (41.6%). Less frequent is the finding of hepatic inflammation or necrosis (19%) and portal inflammation (18%). The presence of microthrombi, frequently found in the lungs, is infrequent in the liver, with only 12% of cases presenting thrombotic formations within the vascular tree.
Conclusion: To date, the greatest problem in interpreting these modifications remains the association of the damage with the direct action of the virus, rather than with the inflammation or alterations induced by hypoxia and hypovolemia in patients undergoing oxygen therapy and decompensated patients.
Keywords: Autopsy; COVID-19; Immunofluorescence; Immunohistochemistry; In situ hybridization; Liver.
©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
Conflict of interest statement
Conflict-of-interest statement: The authors declare no conflict of interest for this article.
Figures


Similar articles
-
A case-control autopsy series of liver pathology associated with novel coronavirus disease (COVID-19).Ann Diagn Pathol. 2024 Feb;68:152240. doi: 10.1016/j.anndiagpath.2023.152240. Epub 2023 Nov 20. Ann Diagn Pathol. 2024. PMID: 37995413
-
High prevalence of hepatic steatosis and vascular thrombosis in COVID-19: A systematic review and meta-analysis of autopsy data.World J Gastroenterol. 2020 Dec 28;26(48):7693-7706. doi: 10.3748/wjg.v26.i48.7693. World J Gastroenterol. 2020. PMID: 33505145 Free PMC article.
-
[Systemic consequences and clinical aspects of SARS-CoV-2 infection].Pathologe. 2021 Mar;42(2):155-163. doi: 10.1007/s00292-021-00913-0. Epub 2021 Feb 11. Pathologe. 2021. PMID: 33575886 Free PMC article. Review. German.
-
Pathological findings in organs and tissues of patients with COVID-19: A systematic review.PLoS One. 2021 Apr 28;16(4):e0250708. doi: 10.1371/journal.pone.0250708. eCollection 2021. PLoS One. 2021. PMID: 33909679 Free PMC article.
-
Direct or Collateral Liver Damage in SARS-CoV-2-Infected Patients.Semin Liver Dis. 2020 Aug;40(3):321-330. doi: 10.1055/s-0040-1715108. Epub 2020 Sep 4. Semin Liver Dis. 2020. PMID: 32886936 Review.
Cited by
-
Combination of spatial transcriptomics analysis and retrospective study reveals liver infection of SARS-COV-2 is associated with clinical outcomes of COVID-19.EBioMedicine. 2025 Jan;111:105517. doi: 10.1016/j.ebiom.2024.105517. Epub 2024 Dec 21. EBioMedicine. 2025. PMID: 39709771 Free PMC article.
-
Diabetes Mellitus, Energy Metabolism, and COVID-19.Endocr Rev. 2024 Mar 4;45(2):281-308. doi: 10.1210/endrev/bnad032. Endocr Rev. 2024. PMID: 37934800 Free PMC article. Review.
-
COVID-19, Possible Hepatic Pathways and Alcohol Abuse-What Do We Know up to 2023?Int J Mol Sci. 2024 Feb 12;25(4):2212. doi: 10.3390/ijms25042212. Int J Mol Sci. 2024. PMID: 38396888 Free PMC article. Review.
-
Management of post-mortem examination in SARS-CoV-19 infections.Pathologica. 2023 Oct;115(5):257-262. doi: 10.32074/1591-951X-921. Pathologica. 2023. PMID: 38054900 Free PMC article. Review.
References
-
- Sun J, Aghemo A, Forner A, Valenti L. COVID-19 and liver disease. Liver Int. 2020;40:1278–1281. - PubMed
-
- Wanner N, Andrieux G, Badia-I-Mompel P, Edler C, Pfefferle S, Lindenmeyer MT, Schmidt-Lauber C, Czogalla J, Wong MN, Okabayashi Y, Braun F, Lütgehetmann M, Meister E, Lu S, Noriega MLM, Günther T, Grundhoff A, Fischer N, Bräuninger H, Lindner D, Westermann D, Haas F, Roedl K, Kluge S, Addo MM, Huber S, Lohse AW, Reiser J, Ondruschka B, Sperhake JP, Saez-Rodriguez J, Boerries M, Hayek SS, Aepfelbacher M, Scaturro P, Puelles VG, Huber TB. Molecular consequences of SARS-CoV-2 liver tropism. Nat Metab. 2022;4:310–319. - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical